See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: April 25, 2005

Multiple Myelomas Malignant Melanoma Diabetic Neuropathy

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Multiple Myelomas

This study will evaluate the spleen during PBPC mobilization by filgrastim. Volunteers 18 years or older with no history of splenectomy, and no previous PBPC mobilization attempts may be eligible. Research sites located in Massachusetts, Missouri and Wisconsin.

More Information

Please see http://www.centerwatch.com/patient/studies/cat212.html.

-----

Malignant Melanoma

This study will evaluate the anticancer agent STA-4783, a taxane potentiator, which enhances the antitumor response of paclitaxel. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat196.html.

-----

Diabetic Neuropathy

This research study will assess the safety and effectiveness of an investigational drug compared with placebo in reducing pain in patients with painful diabetic neuropathy. Research sites located in Texas, Nebraska and Massachusetts.

More Information

Please see http://www.centerwatch.com/patient/studies/cat253.html.

-----

Copyright 2005 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.